跳至主要内容
临床试验/IRCT2012122211841N1
IRCT2012122211841N1已完成未知

Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus

Vice chancellor for Administrative and Financial of Medical School0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • patients with disseminated lichen planus at least 6 months represent to the clinic. Exclusion criteria: 1. Contraindications of heparin and its derivatives, including: hemostasis, acquired or congenital disorder, the risk of bleeding caused by uncontrolled hypertension, active peptic ulcer, recent cerebrovascular accident, sensitivity to enoxaparin or heparin derivatives; 2. Chronic liver disease; 3. Hepatitis B and C; 4. Contraindications for taking oral prednisone; 5. Medications that are known to lead to the LP like reaction; 6. Lichen planus of nails; 7. Scalp involvement; 8. Ulcerated mucosal lesions; 9. Heparin therapy complications such as drug sensitivity, acute bleeding.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Administrative and Financial of Medical School

相似试验

Enoxaparin in treatment of lichen planus | 临床试验